Mielóma multiplex: vizsgálatok itt: Olaszország
75 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 16.. Ask the study team whether a trial fits you.
- No phaseTaking peopleIntegrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
- Where
- Bologna, Catania, Palermo, Reggio Emilia
- Életkor
- 18 év and over
- People
- 60
- Run by
- Azienda USL Reggio Emilia - IRCCS
See details and how to joinNCT07214324 - 3. fázisFut, nem toborozA Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- Where
- Ancona, Catania, Meldola, Palermo, Pavia, Pisa, Rome
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06679101 · EU 2024-516030-35-00 - No phaseTaking peoplePromoting Diagnosis and Management of AL in Italy (ProDigALIty)
- Where
- Bari, Catania, Pavia, Torino
- Életkor
- 18 év to 99 év
- People
- 760
- Run by
- Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT06383143 - 2. fázisTaking peopleStudy for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
- Where
- Ascoli Piceno, Bari, Bergamo, Bologna, Bolzano, Como, Milan, Novara, Pescara, Rome, Turin, Varese
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to joinNCT07107529 · EU 2024-520433-76-00 - No phaseTaking peopleA Prospective Multicenter Study of the Effects of Plant-based Diets on Gut Microbiome and Derived Metabolites in Patients Affected by Smoldering Multiple Myeloma
- Where
- Bari, Milan, Parma
- Életkor
- 18 év to 75 év
- People
- 62
- Run by
- Ciceri Fabio
See details and how to joinNCT07069751 - 1. fázisTaking peopleStudy of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
- Where
- Brescia, Milan
- Életkor
- 18 év and over
- People
- 200 worldwide
- Run by
- Ichnos Sciences SA
See details and how to joinNCT05862012 · EU 2023-507071-21-01 - 1. fázisTaking peopleA Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
- Where
- Rozzano, Torette
- Életkor
- 18 év and over
- People
- 87 worldwide
- Run by
- Sanofi
See details and how to joinNCT06630806 - 3. fázisTaking peopleA Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
- Where
- Alexandria, Ancona, Bari, Bologna, Brescia, Catania, Cuneo, Florence, Genoa, Legnano, Meldola, Milan, Padova, Palermo, Pavia, Reggio Emilia, Rimini, Rome, San Giovanni Rotondo, Turin, Udine
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to joinNCT06932562 · EU 2024-519827-16-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Bologna, Busto Arsizio, Genoa, Meldola, Padua, Perugia, Ravenna, Rome, Turin
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - No phaseTaking peopleInvestigating the Pathogenic Role of N-glycosylation in AL Amyloidosis: Molecular Bases, Diagnosis, and Treatment
- Where
- Pavia
- Életkor
- 18 év to 99 év
- People
- 100
- Run by
- Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT07448779 - No phaseTaking peopleFeasibility of a Multi-omics Platform for Hematological Malignancies
- Where
- Parma
- Életkor
- 2 év and over
- People
- 1040
- Run by
- Azienda Ospedaliero-Universitaria di Parma
See details and how to joinNCT07445438 - No phaseTaking peopleReal-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency
- Where
- Bari, Catania, Padova, Treviso
- Életkor
- 18 év and over
- People
- 75 worldwide
- Run by
- Takeda
See details and how to joinNCT05879757 - No phaseTaking peopleINTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
- Where
- Palermo, Perugia
- Életkor
- 1 év and over
- People
- 300
- Run by
- Azienda Ospedaliero-Universitaria di Parma
See details and how to joinNCT07403630 - No phaseTaking peopleEuropean Myeloma Network (EMN) Sample Project
- Where
- Alessandria, Ancona, Bari, Bologna, Brescia, Civitanova Marche, Florence, Genova, Lecce, Naples, Novara, Pavia, Roma, San Giovanni Rotondo, Terni, Torino, Udine, Vicenza
- Életkor
- 18 év and over
- People
- 6000 worldwide
- Run by
- European Myeloma Network B.V.
See details and how to joinNCT06237803 - No phaseTaking peopleObservational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients
- Where
- Florence
- Életkor
- 18 év and over
- People
- 159
- Run by
- Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT06933277 - No phaseTaking peopleFactors Associated With Health-related Quality of Life and Social Participation of Patients With Multiple Myeloma and Their Caregivers
- Where
- Reggio Emilia
- Életkor
- 18 év and over
- People
- 190
- Run by
- Azienda USL Reggio Emilia - IRCCS
See details and how to joinNCT07014865 - 2. fázisTaking peopleTeclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma
- Where
- Ancona, Bari, Bergamo, Bologna, Bolzano, Brescia, Candiolo, Catania, Florence, Genoa, Padova, Pavia, Reggio Calabria, Reggio Emilia, Rome, Trieste, Turin, Udine, Vicenza
- Életkor
- 18 év and over
- People
- 52
- Run by
- Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT06880601 · EU 2025-521827-61-00 - No phaseTaking peopleWhole Body MRI in Oncology
- Where
- Bologna, Meldola, Milan
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
See details and how to joinNCT06895291 - No phaseTaking peopleReal-World Mapping Antithrombotic Regimens in MM Patients on Treatment
- Where
- Roma
- Életkor
- 18 év and over
- People
- 736
- Run by
- Gruppo Italiano Malattie EMatologiche dell'Adulto
See details and how to joinNCT06028087 - No phaseTaking peopleEfficacy of Isatuximab-based Regimens in Relapsed/Refractory Multiple Myeloma With 1q21+
- Where
- Bologna
- Életkor
- 18 év and over
- People
- 30
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06874530 - No phaseTaking peopleA Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence
- Where
- Bologna, Cagliari, Meldola, Naples
- Életkor
- 18 év and over
- People
- 200
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06767254 - No phaseTaking peopleThe Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia
- Where
- Reggio Emilia
- Életkor
- 18 év and over
- People
- 45
- Run by
- University of Modena and Reggio Emilia
See details and how to joinNCT06236373 - No phaseTaking peopleComparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma
- Where
- Bologna
- Életkor
- 18 év and over
- People
- 83
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
See details and how to joinNCT06659276 - No phaseTaking peopleDAratumumab and REvlimid REfractory MM
- Where
- Pavia
- Életkor
- 18 év and over
- People
- 100
- Run by
- Fondazione IRCCS Policlinico San Matteo di Pavia
See details and how to joinNCT06541860 - No phaseTaking peopleBergamo Lymphoid Cancer Registry
- Where
- Bergamo
- Életkor
- 18 év and over
- People
- 6000
- Run by
- A.O. Ospedale Papa Giovanni XXIII
See details and how to joinNCT03131531